AANA Journal course: update for nurse anesthetists--an overview of multiple sclerosis and implications for anesthesia.
Multiple sclerosis is the most common demyelinating, chronic disease of the central nervous system diagnosed in and affecting young adults. This disease can significantly alter the life of affected people, and there is no known cure. It is important to understand and review this disease process because anesthesia providers are likely to encounter patients with multiple sclerosis in their practice. The purpose of this AANA Journal course is to present an overview of multiple sclerosis. The pathophysiologic features, symptoms, manifestations, diagnosis, and pharmacologic treatment are discussed, with a focus on the implications of multiple sclerosis for general and regional anesthesia.
Schneider
Kristina M
KM
Oakland University Beaumont Graduate Program of Nurse Anesthesia, Royal Oak, Mich, USA.
D000758:Anesthesia / Q000009:adverse effects / Q000379:methods* / Q000451:nursing*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D018450:Disease Progression; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007167:Immunotherapy / Q000379:methods; D008991:Monitoring, Physiologic / Q000379:methods / Q000451:nursing; D009103:Multiple Sclerosis / Q000145:classification / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D009719:Nurse Anesthetists; D024802:Nurse's Role; D009730:Nursing Assessment / Q000379:methods; D018579:Patient Selection; D019990:Perioperative Care / Q000379:methods / Q000451:nursing; D012449:Safety; D012720:Severity of Illness Index
D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents